                         SEQUENCE LISTING

<110>  Her Majesty the Queen in Right of Canada as Represented by 
       the Minister of Health
 
<120>  Influenza Vaccine

<130>  85084-4303

<150>  US 61/173,842
<151>  2009-04-29

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide derived from hemagglutinin of influenza virus

<400>  1

Gly Leu Phe Gly Ala Ile Ala Gly Phe Ile Glu Gly Gly Trp 
1               5                   10                  


<210>  2
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide derived from hemagglutinin of influenza virus

<400>  2

Gly Ile Phe Gly Ala Ile Ala Gly Phe Ile Glu Gly Gly Trp 
1               5                   10                  


<210>  3
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide derived from hemagglutinin of influenza virus

<400>  3

Gly Leu Phe Gly Ala Ile Ala Gly Phe Ile Glu Asn Gly Trp 
1               5                   10                  


<210>  4
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide derived from hemagglutinin of influenza virus

<400>  4

Gly Ile Phe Gly Ala Ile Ala Gly Phe Ile Glu Asn Gly Trp 
1               5                   10                  


<210>  5
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide derived from hemagglutinin of influenza virus

<400>  5

Val Thr Gly Leu Arg Asn Ile Pro Ser Ile Gln Ser Arg 
1               5                   10              


<210>  6
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide derived from hemagglutinin of influenza virus


<220>
<221>  VARIANT
<222>  (2)..(2)
<223>  L or I

<220>
<221>  VARIANT
<222>  (12)..(12)
<223>  G or N

<400>  6

Gly Xaa Phe Gly Ala Ile Ala Gly Phe Ile Glu Xaa Gly Trp 
1               5                   10                  


